| Study of Lemborexant-Alcohol Interaction in Healthy Subjects (NCT03483636) | Eisai Inc. | 2018-03-12 |
| Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors (NCT03430882) | M.D. Anderson Cancer Center | 2018-03-12 |
| Phase 1 Test-retest Evaluation of [18F]MNI-958 PET (NCT03545789) | Invicro | 2018-03-12 |
| An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola (NCT03428347) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-03-12 |
| A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers. (NCT03510611) | Betta Pharmaceuticals Co., Ltd. | 2018-03-12 |
| Study of ARO-AAT in Normal Adult Volunteers (NCT03362242) | Arrowhead Pharmaceuticals | 2018-03-12 |
| Touchscreen-based Cognitive Tests in Healthy Volunteers (NCT03469089) | University of Eastern Finland | 2018-03-12 |
| Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock (NCT05283317) | TC Erciyes University | 2018-03-11 |
| A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment (NCT03425552) | Pharmathen S.A. | 2018-03-11 |
| The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (NCT03460808) | Peking University People's Hospital | 2018-03-10 |
| Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm (NCT03462641) | University of Michigan | 2018-03-09 |
| HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies (NCT03232268) | Institut Paoli-Calmettes | 2018-03-09 |
| Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study (NCT03541252) | Merete Haedersdal | 2018-03-09 |
| A Study of BNC105P Combined With Ibrutinib (NCT03454165) | Dartmouth-Hitchcock Medical Center | 2018-03-09 |
| Radiotherapy of Tongue Cancer Using an Intraoral Stent (NCT04337853) | Oslo University Hospital | 2018-03-09 |
| Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers (NCT03464864) | Mannkind Corporation | 2018-03-09 |
| Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects (NCT03563846) | Ritter Pharmaceuticals, Inc. | 2018-03-09 |
| An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread (NCT03446040) | Bristol-Myers Squibb | 2018-03-08 |
| A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet (NCT03456960) | Takeda | 2018-03-08 |
| Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma (NCT03448978) | Cartesian Therapeutics | 2018-03-08 |
| T Cell Receptor Based Therapy of Metastatic Colorectal Cancer (NCT03431311) | Oslo University Hospital | 2018-03-08 |
| Effects of Low Concentration Atropine on Pupillary Size and Accommodative Amplitude (NCT03699423) | Hai Yen Eye Care | 2018-03-08 |
| A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients (NCT03709628) | Enterome | 2018-03-07 |
| A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors (NCT03465618) | Memorial Sloan Kettering Cancer Center | 2018-03-07 |
| ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma (NCT03441958) | Ciusss de L'Est de l'Île de Montréal | 2018-03-07 |
| A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects (NCT03516331) | Flatley Discovery Lab LLC | 2018-03-07 |
| GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects (NCT03457727) | GlaxoSmithKline | 2018-03-07 |
| An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma (NCT03439761) | SciClone Pharmaceuticals | 2018-03-07 |
| Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus (NCT03462017) | Sanofi | 2018-03-07 |
| M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability (NCT03436563) | M.D. Anderson Cancer Center | 2018-03-07 |
| Phase I/II Study of Avelumab in Pediatric Cancer Participants (NCT03451825) | EMD Serono Research & Development Institute, Inc. | 2018-03-07 |
| A Study of PF-06873600 in People With Cancer (NCT03519178) | Pfizer | 2018-03-07 |
| A Study of LY3074828 in Healthy Participants (NCT03456713) | Eli Lilly and Company | 2018-03-06 |
| CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices (NCT03217331) | Cardiora Pty. Ltd. | 2018-03-06 |
| Anti-platelet + Pembro for H&N Tumors (NCT03245489) | Medical University of South Carolina | 2018-03-06 |
| A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects (NCT03483688) | Peking Union Medical College Hospital | 2018-03-06 |
| A Multiple Ascending Dose Study of COR388 (NCT03418688) | Cortexyme Inc. | 2018-03-06 |
| Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers (NCT03480321) | Genovate Biotechnology Co., Ltd., | 2018-03-06 |
| A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants (NCT03467971) | Merck KGaA, Darmstadt, Germany | 2018-03-06 |
| Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s (NCT03457597) | Corcept Therapeutics | 2018-03-06 |
| A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a Single Oral Dose of Lumicitabine (JNJ-64041575) in Healthy Adult Participants (NCT03468777) | Janssen Research & Development, LLC | 2018-03-06 |
| Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors (NCT03245450) | Eisai Inc. | 2018-03-05 |
| Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse (NCT03356054) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2018-03-05 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers (NCT03013881) | United BioPharma | 2018-03-05 |
| Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers (NCT03382964) | Valneva Austria GmbH | 2018-03-05 |
| An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants (NCT03419910) | Bristol-Myers Squibb | 2018-03-05 |
| A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment (NCT03307915) | Janssen Vaccines & Prevention B.V. | 2018-03-05 |
| Hypertrophic Scar Prevention by Novel Topical Gel Application (NCT03403621) | Mayo Clinic | 2018-03-05 |
| A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants (NCT03329209) | Takeda | 2018-03-05 |
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262) | St. Jude Children's Research Hospital | 2018-03-05 |
| Central Nervous System Vascular Changes in Adult Sickle Cell Disease and the Effect of Treatment With Simvastatin (NCT03599609) | University of Campinas, Brazil | 2018-03-05 |
| A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects (NCT03496506) | Actelion | 2018-03-05 |
| Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors (NCT03415659) | Hubei Biological Medicine Industrial Technology Institute Co., Ltd. | 2018-03-05 |
| Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein (NCT03462004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-03-05 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD (NCT03339973) | RHEACELL GmbH & Co. KG | 2018-03-05 |
| Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT03478995) | Genexine, Inc. | 2018-03-05 |
| Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss (NCT03435250) | Institut de Recherches Internationales Servier | 2018-03-04 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers (NCT03411421) | Alios Biopharma Inc. | 2018-03-03 |
| Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia (NCT03431090) | Nationwide Children's Hospital | 2018-03-02 |
| Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas (NCT03423992) | Xuanwu Hospital, Beijing | 2018-03-02 |
| A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects Under Fed Conditions (NCT03424135) | Bayer | 2018-03-02 |
| Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream (NCT04358770) | Sun Pharmaceutical Industries, Inc. | 2018-03-02 |
| A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects (NCT03444402) | Chong Kun Dang Pharmaceutical | 2018-03-02 |
| Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) (NCT03463733) | M.E. van Linde | 2018-03-02 |
| Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) (NCT03167151) | University of Oxford | 2018-03-02 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies (NCT03638206) | Shenzhen BinDeBio Ltd. | 2018-03-01 |
| Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) (NCT02313844) | AlloVir | 2018-03-01 |
| To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers (NCT03415243) | GlaxoSmithKline | 2018-03-01 |
| Recovery From Plantar Heel Pain Using the Fascial Distortion Model a Pilot Study (NCT04571073) | Eisenhower Army Medical Center | 2018-03-01 |
| Safety and Immunogenicity Study of GX-70 in TB Patient (NCT03159975) | Yonsei University | 2018-03-01 |
| The Study About Mechanism of Transcranial Magnetic Stimulation Treatment of Depression Using Medical Imaging (NCT03500029) | Xi'an Jiaotong University | 2018-03-01 |
| CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML） (NCT03556982) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2018-03-01 |
| Phase I Study of APX005M in Pediatric Central Nervous System Tumors (NCT03389802) | Pediatric Brain Tumor Consortium | 2018-03-01 |
| A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416 (NCT03283098) | Amgen | 2018-03-01 |
| PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients (NCT03436056) | Royal Marsden NHS Foundation Trust | 2018-03-01 |
| Effects of Oxytocin Dose Frequency on Behavioral and Neural Responses (NCT03610919) | University of Electronic Science and Technology of China | 2018-03-01 |
| Cerebrovascular Reactivity in American Football Players (NCT03417492) | University of Pennsylvania | 2018-03-01 |
| Phase I EGFR BATs in Newly Diagnosed Glioblastoma (NCT03344250) | University of Virginia | 2018-03-01 |
| A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer (NCT03425292) | Saint John's Cancer Institute | 2018-03-01 |
| Inter- and Intra-individual Variations in Metformin Pharmacokinetics - The Importance of Genes and Drug Interactions (NCT03335423) | University of Southern Denmark | 2018-03-01 |
| Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb Ischemia (NCT02993809) | South China Research Center for Stem Cell and Regenerative Medicine | 2018-03-01 |
| Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases (NCT03757858) | Capital Medical University | 2018-03-01 |
| Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors (NCT03474289) | Jiangsu HengRui Medicine Co., Ltd. | 2018-03-01 |
| Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME (NCT03384524) | Andrew Moshfeghi, MD, MBA | 2018-03-01 |
| A Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular Lymphoma (NCT03221348) | Cho Pharma Inc. | 2018-03-01 |
| A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors (NCT03361228) | Incyte Corporation | 2018-03-01 |
| CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL） (NCT03544021) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2018-03-01 |
| Bioavailability and Impact of Coenzyme Q10 in Stressing Exercise in Senescence Athletes (NCT03893864) | Centre d'Alt Rendiment | 2018-03-01 |
| Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer (NCT03225989) | Lokon Pharma AB | 2018-03-01 |
| Chloroquine for Glioblastoma. (NCT04772846) | Egyptian Medical Syndicate | 2018-03-01 |
| Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma (NCT02719015) | M.D. Anderson Cancer Center | 2018-03-01 |
| Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386) (NCT03311841) | Merck Sharp & Dohme LLC | 2018-03-01 |
| Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells (NCT04446884) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2018-03-01 |
| The Safety and Tolerability of Pirfenidone for BOS After HCT (NCT03315741) | Stanford University | 2018-03-01 |
| Evaluation of Testosterone Nasal Gel in Hypogonadal Boys (NCT03345797) | Acerus Biopharma Inc. | 2018-03-01 |
| Automated Abdominal Binder for Orthostatic Hypotension (NCT03482297) | Vanderbilt University Medical Center | 2018-03-01 |
| Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell Lymphomas (NCT03205891) | M.D. Anderson Cancer Center | 2018-03-01 |
| Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations (NCT03404817) | Embera NeuroTherapeutics, Inc. | 2018-03-01 |
| Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma (NCT03223103) | Adilia Hormigo | 2018-03-01 |
| Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery (NCT03446911) | Amsterdam UMC, location VUmc | 2018-03-01 |